Keith Regnante insider trades

Open-market stock purchases and sales by Keith Regnante, CHIEF FINANCIAL OFFICER at Keros Therapeutics, Inc, from SEC Form 4 filings since Aug 16, 2016.

Recent trades

DateStockTradeValue
Feb 24, 2026KROS Keros Therapeutics, IncBought (not open market)—
Feb 18, 2026KROS Keros Therapeutics, IncSold$77.5K

Companies traded

  • KROS Keros Therapeutics, Inc: 8 sales, last Feb 24, 2026
  • WVE Wave Life Sciences Ltd: 2 sales, last Sep 24, 2018

Get free alerts when Keith Regnante files a new trade →